• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Sun Pharmaceutical Industries Ltd.
    16 Jun 2025
    1591.70
    0.68%
    Sun Pharma share slips 2% as USFDA flags 8 observations for Halol facility
    Business Standard
    Sun Pharma shares dropped in trade after the company announced that United States Food and Drug Administration (USFDA) has issued a Form-483, with 8 observations for its Halol facility in Gujarat.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below all available SMAs
    Sun Pharma Share Price Fell Nearly 2% After US FDA Issues Eight Observations
    NDTV Profit | 16 Jun 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    14 Jun 2025
    1591.70
    0.68%
    Sun Pharma gets 8 observations from USFDA for Halol plant
    Business Line
    The USFDA conducted a good manufacturing practices inspection at the Halol facility from June 2-13 2025, the Mumbai-based drug maker said in a regulatory filing
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    Sun Pharma Elevates Kirti Ganorkar As Managing Director
    NDTV Profit | 14 Jun 2025 3 more
    Succession planning at Sun Pharma: Kirti Ganorkar appointed as Managing Director
    Business Line | 13 Jun 2025
    Sun Pharma starts succession plan; Ganorkar succeeds Shanghvi as MD
    Business Standard | 13 Jun 2025
    Sun Pharma appoints Kirti Ganorkar as MD after shareholders' approval
    Business Standard | 13 Jun 2025
    logo
    Natco Pharma Ltd.
    13 Jun 2025
    841.25
    -0.57%
    NATCO Pharma's Hyderabad API Manufacturing Facility Gets One Observation From USFDA
    NATCO Pharma's Hyderabad API Manufacturing Facility Gets One Observation From USFDA
    NDTV Profit
    The investigation was conducted from June 9 to June 13, 2025.
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. is trading below all available SMAs
    logo
    Jubilant Pharmova Ltd.
    13 Jun 2025
    1109.60
    0.33%
    Why is Jubilant Pharmova share price buzzing in an overall weak market?
    Business Standard
    Jubilant Pharmova shares rose after its board approved the slump sale of its API business to wholly-owned subsidiary, Jubilant Biosys.
    Copy LinkShare onShare on Share on Share on
    Jubilant Pharmova Ltd. has gained 21.92% in the last 6 Months
    logo
    Eris Lifesciences Ltd.
    12 Jun 2025
    1710.00
    -0.09%
    Eris soars 11% on Thursday, zooms 61% from low; is it time to book profit?
    Business Standard
    The stock of the pharmaceutical company Eris Lifesciences was trading higher for the third straight day, soaring 17 per cent during the period.
    Copy LinkShare onShare on Share on Share on
    Eris Lifesciences Ltd. is trading below its 30 day SMA of 1756.3
    logo
    Mankind Pharma Ltd.
    12 Jun 2025
    CDSCO Approval
    2589.30
    0.38%
    Nirmal Bang Maintains 'Hold' On Mankind Pharma Shares, Revises Target Price Here's Why
    Nirmal Bang Maintains 'Hold' On Mankind Pharma Shares, Revises Target Price Here's Why
    NDTV Profit
    Nirmal Bang maintain Hold rating on Mankind Pharma with a revised target price of Rs 2,650, valuing it at 25x on FY27E EV/Ebitda.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. is trading above all available SMAs
    logo
    Biocon Ltd.
    12 Jun 2025
    364.50
    0.10%
    Stock Market Live Updates 12 June 2025: Stock to buy today: Biocon (354.30)
    Business Line
    Sensex, Nifty, Share Prices LIVE: The upmove in the stock of Biocon seems to be gaining momentum. The strong 3.8 per cent rise on Wednesday has taken the share price well above a key resistance level of 348. It also signals that the consolidation that was in place since mid-February this year has come to an end. The region between 348 and 340 will now act as a strong support zone and limit the downside. Biocon share price can rise to 400 in the coming weeks. Traders can buy Biocon shares now at 354
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. is trading above its 200 day SMA of 353.6
    Today's Stock Recommendation: June 12, 2025
    Business Line | 12 Jun 2025 1 more
    Stock to buy today: Biocon (354.30) BUY
    Business Line | 12 Jun 2025
    logo
    OneSource Specialty Pharma Ltd.
    11 Jun 2025
    1837.80
    0.14%
    OneSource Specialty Pharma partners with Swedish biotech company Xbrane, on its biosimilar portfolio
    Business Line
    As part of the agreement, Xbrane will undertake a tech-transfer of its commercial product to OneSource's integrated drug substance and drug product facility in Bengaluru
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 4.95% of shares in last quarter. Total pledge stands at 25.01% of promoter holdings
    logo
    Marksans Pharma Ltd.
    11 Jun 2025
    172.00
    1.48%
    Marksans Pharma shares surge 5% after block trades; details here
    Business Standard
    Marksans Pharma shares rose 5 per cent after 10.27 million shares changed hands via multiple pre-market block trades
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 153 to 159 in Jun 2025 qtr.
    logo
    Sun Pharmaceutical Industries Ltd.
    11 Jun 2025
    1591.70
    0.68%
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    NDTV Profit
    Nirmal Bang maintains Buy rating underpinned by Sun Pharma's strong positioning as a unique play on both the India branded market and the global specialty pharma opportunity.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below all available SMAs
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd